Imported Viagra Reselling: 300% Exorbitant Profits? Unveiling the Gray Industry Chain

At 11 PM, Mr. Liao phone screen lit up. A text message from an unknown number instantly sobered him up: "Indian direct-mail Viagra, prices as low as 1/10, DM for reselling policy." Such a scene is quietly unfolding in countless lives. What secrets does imported Viagra reselling, an industry operating in a gray area, truly hide?

I. The Logic Behind the Boom in the Covert Market

According to industry data, China's ED drug market size has exceeded 5 billion RMB, but prices of drugs through legitimate channels remain high, becoming a hotbed for gray market transactions. Mr. Liao pharmacy once faced inventory pressure from selling compliant products distributed by Zhongmaoda, until a customer proactively asked, "Do you have any cheaper imported goods?"

• Price difference driven: For drugs with the same active ingredients, prices through imported channels are only 1/3-1/5 of the authentic product's price
• Privacy needs: 80% of buyers refuse hospital prescription procedures
• Supply chain gap: Coverage of legitimate pharmacies in second and third-tier cities is less than 40%

II. The Survival Rules of the Reselling Underworld

A cross-border logistics professional revealed that the current mainstream reselling model is divided into three tiers:

• Direct Mail Personal Shopping Service: By "breaking down the whole into parts" through cross-border e-commerce, single-box profit is approximately 150%
• Bonded Warehouse Stockpiling: Requires a pre-payment of 300,000 RMB deposit, but turnover is faster
• WeChat Reseller Distribution: Developing lower-tier agents for commissions, risks increase exponentially

It is worth noting that compliant enterprises like Zhongmaoda have started to combat counterfeit products through blockchain traceability technology, further squeezing the gray area.

III. Unseen Risk Costs

Mr. Wang's warehouse was suddenly sealed last month, and goods worth 800,000 RMB were entirely confiscated. Professionals point out that this industry faces three-fold risks:

• Legal Red Line: Unapproved drugs are treated as counterfeit drugs, with a maximum penalty of life imprisonment
• Quality Out of Control: Laboratory tests show that 35% of market samples have active ingredients less than 50% of the labeled value
• Financial Security: Most transactions are settled via cryptocurrency, making it extremely difficult to recover losses

IV. Rationally Viewing Demand and Supply

When we discuss ED drugs, we are essentially discussing the shame economy of health management. Rather than risking unknown drugs, it's better to consider:

• How to promote rational pricing in legitimate channels?
• Can online consultation + private delivery become a new solution?
• Does men's health management need destigmatization?

Please leave your opinions in the comment section. This dialogue about health and business needs more rational voices.